Pic Courtesy: - New Delhi: Asked by CCI to divest seven products, drug makers Sun Pharmaceutical and Ranbaxy on Monday said they will comply with the conditions put forth by the fair trade regulator to take forward their proposed merger. While ... ZeeNews.com, 1 week ago
Fortis Healthcare on Thursday reported a consolidated net loss of Rs 58.12 crore for the quarter ended September. The company had posted a net profit after taxes, minority interest and share of profit of associates at Rs 32.06 crore for the ...Business Today India, 1 month ago Fortis Q2 net loss at Rs 58 cr Hindu Business Line, 1 month ago Fortis Healthcare CEO Aditya Vij quits...stock down 4% India Infoline, 1 month ago Fortis reports Rs 58 cr loss for Q2; CEO Aditya Vij steps down ZeeNews.com, 1 month ago
If Ranbaxy had to survive, it would have to grow abroad, induct professionals and invest in research, notes Bhupesh Bhandari Ranbaxy tasted success for the first time in the 1960s with its tranquiliser, Calmpose. The drug, diazepam, was owned by Roche but it hadn’t sought patent protection for it in India. Bhai Mohan Singh, who ran Ranbaxy at that time, located a drug maker in the Soviet Bloc which agreed to supply him as much diazepam as he wanted. Calmpose went on to become ...Rediff.com, 1 month ago 40 Years Ago... And now: Ranbaxy grew with liberal regimes, moving out of family control Business Standard India, 1 month ago
on your WebpageAdd Widget >Get your members hooked!